-
3-Methyladenine: Autophagy Research Guide
2026-08-28
3-Methyladenine (3-MA) is a widely used autophagy research tool that inhibits class III phosphoinositide 3-kinase activity through Vps34-associated signaling. Its time-dependent effects on class I and class III PI3K require matched controls, flux measurements, and cautious interpretation in cancer research.
-
AZD6482 for Reliable Cell Assays
2026-08-28
AZD6482 (SKU A5478) provides a data-backed starting point for selective PI3Kβ perturbation in cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers concentration selection, solvent control, assay interpretation, cross-domain limitations, and practical supplier evaluation.
-
Influenza Hemagglutinin (HA) Peptide Workflow
2026-08-27
Use the HA tag peptide to elute tagged proteins under gentle, antibody-competitive conditions while preserving protein interactions that harsh methods can disrupt. This workflow connects reproducible HA-tag purification with mechanistic assays inspired by the NEDD4L–PRMT5 colorectal cancer study.
-
Alternariol and the Fibrosis Translation Gap
2026-08-27
Alternariol (AOH) is more than an emerging foodborne mycotoxin: it is a mechanistically rich research tool for connecting environmental exposure with hepatic stellate cell activation, apoptosis, cytochrome P450 biology, and fibrosis-related phenotypes. This thought-leadership article examines recent LX-2 omics evidence, outlines practical study parameters, compares AOH with related Alternaria toxins, and identifies the limitations that translational researchers must address before moving toward risk assessment or detoxification strategies.
-
Nifedipine (BAY-a-1040) Assay Workflows
2026-08-26
Nifedipine (BAY-a-1040) provides a practical way to perturb L-type calcium signaling while preserving clear separation between established calcium assays and exploratory liver, iron, and fungal applications. This workflow emphasizes solvent control, orthogonal readouts, and careful interpretation of PXR-related findings rather than treating nifedipine as a PXR agonist.
-
PD0325901: Linking MEK Signals to Cell Fate
2026-08-26
PD0325901 is a selective MEK inhibitor that connects RAS/RAF/MEK/ERK pathway perturbation with proliferation, apoptosis, and cell-fate analysis. This article develops an assay framework inspired by new WDR36–glycolysis findings in human blastoid models while clearly separating established evidence from exploratory applications.
-
TAK-715: Selective p38 MAPK Inhibitor
2026-08-25
TAK-715 is a selective p38 MAPK inhibitor that targets p38α with a reported IC50 of 7.1 nM. Product data support its use in cytokine signaling modulation, inflammation studies, and rheumatoid arthritis research, while mechanistic evidence on dual-action p38α inhibition should not be attributed to TAK-715 without direct testing.
-
SIRT3–SUMO Control of Treg Differentiation in Asthma
2026-08-25
Hu and Liu identify a metabolic mechanism linking SIRT3 SUMOylation, fatty acid oxidation, N-glycosylation, and regulatory T-cell differentiation in asthma. The study combines bioinformatic network analysis, an OVA-sensitized asthma model, primary CD4+ T-cell differentiation, and molecular perturbation to connect immune-cell phenotype with metabolic control, while also suggesting practical assays for separating proliferation from differentiation.
-
Thapsigargin: From Calcium Stress to Translation Strategy
2026-08-24
Thapsigargin is more than a calcium-depletion reagent: it is a controllable SERCA pump inhibitor for connecting intracellular calcium homeostasis with ER stress, apoptosis, and translational control. This thought-leadership guide shows how researchers can use it to build mechanistically resolved, translationally relevant experiments without confusing an acute pharmacological perturbation with a disease mechanism.
-
Tiamulin Metabolism Across Farm Animal Species
2026-08-23
The reference study used UHPLC–quadrupole/time-of-flight mass spectrometry to map Tiamulin biotransformation across rats, chickens, swine, goats, and cows, identifying 26 metabolites and substantial interspecies variation. Its findings refine candidate marker residues for regulatory monitoring, particularly in swine and chickens, and show why metabolism data should not be transferred between species without validation.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-08-22
This 2025 review frames tumor hypoxia and immune-cell metabolism as interconnected forces that shape nutrient competition, immune suppression, and malignant progression. Its main practical contribution is a mechanism-based framework for designing experiments and therapies that evaluate oxygen availability, glucose use, and tumor–immune interactions together rather than as isolated variables.
-
Reserpine (N1867): Practical Lab Workflow
2026-08-21
Reserpine (SKU N1867) provides a characterized research compound for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. It is intended for laboratory use only; it should not be used for diagnostic, clinical, therapeutic, or veterinary applications.
-
Midecamycin In Vitro Activity: 1983 Study Analysis
2026-08-20
Harold C. Neu’s study mapped the in vitro spectrum of midecamycin, an acetoxy-substituted macrolide, across clinically derived gram-positive and gram-negative isolates. The results showed useful activity against many streptococci, staphylococci, Haemophilus influenzae, and Listeria, but lower potency than erythromycin and no reliable activity against erythromycin-resistant strains or most gram-negative bacilli.
-
HyperScribe All in One mRNA Synthesis Kit Guide
2026-08-20
The HyperScribe All in One mRNA Synthesis Kit is an ARCA capped mRNA synthesis kit that combines T7 transcription, DNase I template removal, and enzymatic poly(A) tailing. Its product specifications support up to 25 reactions and up to 50 μg of RNA per reaction under the stated control-template condition, making it relevant to mRNA vaccine synthesis, in vitro translation mRNA preparation, and RNA interference workflows.
-
Sulfo-Cy5 Carboxylic Acid for Mucosal Imaging
2026-08-19
Sulfo-Cy5 carboxylic acid combines aqueous compatibility with far-red fluorescence for tracking labeled biomolecules, nanoparticles, and tissue-localization workflows. This guide translates a recent PLGA nano-adjuvant study into practical imaging, labeling, controls, and troubleshooting strategies.
445 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page